🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Meng Lv

Peking University

ORCID: 0000-0001-6625-9523

Also affiliated with Peking University People's Hospital

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 4 papers. Top paper: The efficiency and safety of trastuzumab and lapatinib added to neoadjuvant chemotherapy in Her2-positive breast cancer patients: a randomized meta-analysis.

11 citations

Yanwei Shen, Shuting Li, Meng Lv, Jiao Yang, Ling-Xiao Zhang +5 more

3 citations

Tyler Funnell, Nicholas R. Waters, Sandeep Raj, Keimya Sadeghi, Anqi Dai +9 more

11 citations

Tyler Funnell, Nicholas R. Waters, Sandeep Raj, Mirae Baichoo, Keimya Sadeghi +10 more

0 citations

Jun Kong, Meng Lv, Xiao‐Dong Mo, Yu‐Qian Sun, Yi‐Fei Cheng +5 more